Insulet Corporation [PODD] stock prices are up 5.91% to $175.49 at the moment. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The PODD shares have gain 7.01% over the last week, with a monthly amount drifted -12.09%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 5, March 2024, Insulet to Present Results from First Omnipod® 5 Randomized Controlled Trial (OP5-003) at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD). In a post published today on Yahoo Finance, Conducted in the United States and France, the OP5-003 Trial is the first Omnipod 5 study to include international participants.
From an analyst’s perspective:
Insulet Corporation [NASDAQ: PODD] stock has seen the most recent analyst activity on December 21, 2023, when Robert W. Baird upgraded its rating to a Outperform and also boosted its price target to $238 from $180. Previously, Morgan Stanley upgraded its rating to Overweight on December 04, 2023, and elevated its price target to $234. On October 02, 2023, upgrade upgraded it’s rating to Buy and revised its price target to $240 on the stock. Citigroup upgraded its rating to a Buy and decreased its price target to $265 on August 21, 2023. Robert W. Baird downgraded its rating to a Neutral and reduced its price target to $219 on August 21, 2023. In a note dated January 26, 2023, Wolfe Research initiated an Peer Perform rating.
The stock price of Insulet Corporation [PODD] has been fluctuating between $125.82 and $335.91 over the past year. Currently, Wall Street analysts expect the stock to reach $309.58 within the next 12 months. Insulet Corporation [NASDAQ: PODD] shares were valued at $175.49 at the most recent close of the market. An investor can expect a potential return of 76.41% based on the average PODD price forecast.
Analyzing the PODD fundamentals
The Insulet Corporation [NASDAQ:PODD] reported sales of 1.70B for trailing twelve months, representing a surge of 37.90%. Gross Profit Margin for this corporation currently stands at 0.68% with Operating Profit Margin at 0.13%, Pretax Profit Margin comes in at 0.13%, and Net Profit Margin reading is 0.12%. To continue investigating profitability, this company’s Return on Assets is posted at 0.08, Equity is 0.34 and Total Capital is 0.1. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of1.94.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 168.51 points at the first support level, and at 161.52 for the second support level. However, for the 1st resistance point, the stock is sitting at 181.20, and for the 2nd resistance point, it is at 186.90.
Ratios To Look Out For
It’s worth pointing out that Insulet Corporation [NASDAQ:PODD]’s Current Ratio is 3.47. Also, the Quick Ratio is 2.58, while the Cash Ratio stands at 1.44. Considering the valuation of this stock, the price to sales ratio is 7.23, the price to book ratio is 16.74 and price to earnings (TTM) ratio is 60.26.
Transactions by insiders
Recent insider trading involved Petrovic Shacey, Director, that happened on Feb 28 ’24 when 11609.0 shares were sold. Director, BORIO LUCIANA completed a deal on Dec 15 ’23 to sell 72.0 shares. Meanwhile, Director Petrovic Shacey sold 20000.0 shares on Nov 13 ’23.
